PT  - JOURNAL ARTICLE
AU  - Rotulo, Arianna
AU  - Kondilis, Elias
AU  - Thwe, Thaint
AU  - Gautam, Sanju
AU  - Torcu, Özgün
AU  - Vera-Montoya, Maira
AU  - Marjan, Sharika
AU  - Gazi, Md Ismail
AU  - Putri, Alifa Syamantha
AU  - Hasan, Rubyath Binte
AU  - Mone, Fabia Hannan
AU  - Rodríguez-Castillo, Kenya
AU  - Tabassum, Arifa
AU  - Parcharidi, Zoi
AU  - Sharma, Beverly
AU  - Islam, Fahmida
AU  - Amoo, Babatunde
AU  - Lemke, Lea
AU  - Gallo, Valentina
TI  - Mind The Gap: Data availability, accessibility, transparency, and credibility during the COVID-19 pandemic, an international comparative appraisal
AID  - 10.1101/2022.09.14.22279961
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.09.14.22279961
4099  - http://medrxiv.org/content/early/2022/09/15/2022.09.14.22279961.short
4100  - http://medrxiv.org/content/early/2022/09/15/2022.09.14.22279961.full
AB  - Background Data transparency has played a key role in this pandemic. The aim of this paper is to map COVID-19 data availability and accessibility, and to rate their transparency and credibility in selected countries, by the source of information. This is used to identify knowledge gaps, and to analyse policy implications.Methods The availability of a number of COVID-19 metrics (incidence, mortality, number of people tested, test positive rate, number of patients hospitalised, number of patients discharged, the proportion of population who received at least one vaccine, the proportion of population fully vaccinated) was ascertained from selected countries for the full population, and for few of stratification variables (age, sex, ethnicity, socio-economic status) and subgroups (residents in nursing homes, inmates, students, healthcare and social workers, and residents in refugee camps).Results Nine countries were included: Bangladesh, Indonesia, Iran, Nigeria, Turkey, Panama, Greece, the UK, and the Netherlands. All countries reported periodically most of COVID-19 metrics on the total population. Data were more frequently broken down by age, sex, and region than by ethnic group or socio-economic status. Data on COVID-19 is partially available for special groups.Conclusions This exercise highlighted the importance of a transparent and detailed reporting of COVID-19 related variables. The more data is publicly available the more transparency, accountability, and democratisation of the research process is enabled, allowing a sound evidence-based analysis of the consequences of health policies.Funding This study was conducted as part of the Summer School “Sustainable Health: designing a new, better normal after COVID-19”. It is a researchers/student collaboration.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNAClinical Protocols NA Funding StatementThis research paper is a student-teacher collaboration during the Summer School 2021 at University of Groningen. No additional fund was used for writing the paperAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No ethical committee approval required as no individuals have been involved in this research and only publicly available data were usedI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Not ApplicableData originates from publicly available sources in different languages and countries NA